Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Long-Term Investments (2019 - 2026)

Inspire Medical Systems' Long-Term Investments history spans 8 years, with the latest figure at $115.9 million for Q1 2026.

  • On a quarterly basis, Long-Term Investments rose 158.49% to $115.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $115.9 million, a 158.49% increase, with the full-year FY2025 number at $96.3 million, up 35.69% from a year prior.
  • Long-Term Investments hit $115.9 million in Q1 2026 for Inspire Medical Systems, up from $96.3 million in the prior quarter.
  • Over the last five years, Long-Term Investments for INSP hit a ceiling of $115.9 million in Q1 2026 and a floor of $3.0 million in Q3 2023.
  • Historically, Long-Term Investments has averaged $59.6 million across 5 years, with a median of $57.9 million in 2024.
  • Biggest five-year swings in Long-Term Investments: skyrocketed 4701.96% in 2022 and later decreased 22.1% in 2025.
  • Tracing INSP's Long-Term Investments over 5 years: stood at $9.8 million in 2022, then dropped by 6.67% to $9.1 million in 2023, then soared by 676.5% to $71.0 million in 2024, then soared by 35.69% to $96.3 million in 2025, then rose by 20.3% to $115.9 million in 2026.
  • Business Quant data shows Long-Term Investments for INSP at $115.9 million in Q1 2026, $96.3 million in Q4 2025, and $88.4 million in Q3 2025.